ART Assisted reproductive technology Dithawut Khrutmuang MD.

Slides:



Advertisements
Similar presentations
In Vitro Fertilization
Advertisements

Reproductive Hormones
The use of hCG in microdose to support ovarian folliculgenesis Michel Abou Abdallah, M.D.
Ovarian Ageing and Fertility
 OHSS is a serious, potentially life- threatening, iatrogenic complication of “controlled” ovarian stimulation.  To optimize the ovarian response without.
ART-IVF: the Long and Short of it Professor Ernest Hung Yu NG Department of Obstetrics & Gynaecology The University of Hong Kong.
Infertility. Definitions Failure to conceive within 2 years of regular unprotected intercourse. Primary or secondary. 84% of couples will conceive within.
Elonva in poor responders
Female Reproductive System
Think about… 4.1 Hormonal control of the menstrual cycle 4.2 Use of hormones Recall ‘Think about…’ Summary concept map.
INFERTILITY. DEFINITION of Infertility What is Infertility? Infertility is defined two years of unprotected intercourse without pregnancy. (WHO, one year)
Minimal Monitoring of Ovulation Induction (OI) Is It Safe? Mustafa Uğur Zekai Tahir Burak Women’s Health Education and Research Hospital, Ankara, Turkey.
Female Reproductive function and cycles
Infertility I. Fertility  BBT & Cervical Changes  Home Ovulation Prediction II. Causes of infertility  Male factor infertility  Tubal Infertility 
WHAT IS IVF? In vitro fertilization (IVF) is a process by which egg cells are manually fertilized by sperm outside of the womb. IVF is a major treatment.
Role of Anti-Mullerian hormone in prediction of Assisted Reproductive Technology outcomes Leili Safdarian M.D. Khadigeh Khosravi M.D. Marzieh Agha Hosseini.
In Vitro Fertilization by Ms. Mann. Assessment Statements Outline the process of in vitro fertilization (IVF) Discuss the ethical issues associated.
By the end of this lecture you will be able to: Recall how ovulation occurs and specify its hormonal regulation Recognize causes and types of female infertility.
Menstrual Cycle.
The uses of antagonist in IVF/ICSI cycle Prof. Dr. Mohamed Said Elmahaishi Lamis IVF Centre Misurata/ Libya 5 th International Congress In Infertility.
Outline Definition Signs and symptoms Process of conception Types of infertility Causes of infertility Diagnostic studies ComplicationTreatmentPreventionSummaryReferences.
Infertility Grand Challenge Seminar Fall, What is infertility? Infertility is the term health care providers use for women of normal childbearing.
Menstrual Cycle Regulation
The Hormones GnRH = gonadotropin-releasing hormone FSH = Folicle-stimulating hormone LH = Luteinizing hormone Testosterone Estrogen Progesterone.
TEMPLATE DESIGN © Oocyte donation outcomes at Alpha International Fertility Centre IntroductionResultsConclusions References.
In Vitro Fertilization Hariom Yadav 1, Shalini Jain 1 and Mukesh Yadav 2 1 Animal Biochemistry Division, National Dairy Research Institute, Karnal ,
Treatment Options for Infertility
Chapter 15 Reproductive System.
Dr. Milton Leong Director
Accelerated Biology.  Some important vocabulary  Follicle – a cluster of cells that surrounds an immature egg and provides it with nutrients (where.
Human Reproduction 6.6.
The process of a male gamete (sperm) fertilizing a female gamete (egg or ovum)
Agonist vs Antagonist Dr. Milton Leong.
Recommended Dosage of GnRH Antagonist is Too High Presented by Dr. Milton Leong, MD DSc(McGill) Director, IVF Centre.
PHYSIOLOGY OF THE MENSTRUAL CYCLE
Methods of assisted reproduction MUDr.Jitka Řezáčová ÚPMD, Praha 4, Podolí.
The Challenge of the Miracle of Life - Infertility Jennifer McDonald DO.
A review on the luteal phase P Devroey MD PhD Centre for Reproductive Medicine Dutch-speaking Brussels Free University Brussels - Belgium.
Secondary Sex Traits. Hormones – Proteins made in the brain and sex organs Hormones – Proteins made in the brain and sex organs.
Reproductive Systems Chapter 16.
Human Reproductive Systems Chapter 50, section 3 only.
FERTILITY TREATMENT AND IVF TYPES OF TREATMENT & THE PSYCHOLOGICAL EFFECTS.
Female Reproductive Cycle
Physiology and health Unit 2. 1 Reproduction (a) (i)The structure and function of reproductive organs and gametes and their role in fertilisation. Gamete.
(Miz Medi Hospital) Jung-Hyun Cho, M.D. (Miz Medi Hospital) Minimal Ovarian Stimulation.
ART & Fertility Massage Clare Blake N.D. Fertility Massage Therapy & Training.
Assisted ReproductionBy Dr Shaimaa Kadhim AL-Khafajy.
Fertility Facts Definition:unprotected sex for one year, not pregnant
INTRAUTERINE DEVICES- A HIGHLY EFFECTIVE METHOD OF CONTRACEPTION By Megan Klein.
Product Order By Top Drug Mart Online
Biology 12 THE FEMALE MENSTRUAL CYCLE.  The menstrual cycle is the term for the physiological changes that can occur in fertile women for the purposes.
Jeannie Harper, PhD, RN Southeastern Louisiana University.
Welcome.
Menotropins Drugbank ID : DB00032
The timeline shows the day of menstrual cycle for a typical patient
How IVF Protocols Work to Enhance the Success of IVF: Agonist vs Antagonist Dr Dimitrios Dovas MD Newlife IVF Greece.
ultrasound of the female pelvis
Drug protocols for ovulation induction. A
Drug protocols for ovulation induction. A
Use of GnRH antagonists for IVF
Chorionic Gonadotropin (Recombinant)
Drug protocols for ovulation induction. A
Chapter 17 Female Reproduction.
Female Reproductive System
Human Reproduction The Menstrual Cycle.
Reproductive Hormones
Introduction QUICK START: Controlled Ovarian Hyperstimulation Cycle.
QUICK START: Introduction
Introduction QUICK START: Controlled Ovarian Hyperstimulation Cycle.
Presentation transcript:

ART Assisted reproductive technology Dithawut Khrutmuang MD.

Assisted reproductive technology All treatments or procedures which include the handling of human oocytes or embryos, including in vitro fertilization, gamete intrafallopian transfer, zygote intrsifallopian transfer, and such other specific technologies as the Secretary may include in this definition Fertility Clinic Success Rate and Certification Act

Assisted Reproductive Technology (ART) In vitro fertilization-embryo transfer (IVF-ET)/intracytoplasmic sperm injection (ICSI) Gamete intrafallopian transfer (GIFT)/ Zygote intrafallopian transfer (ZIFT) Frozen embryo transfer (FET). ART may be recommended when other treatments (such as intrauterine insemination) have not been successful or when there is severe male factor infertility, severe endometriosis or tubal obstruction the American Society for Reproductive Medicine

Evaluation before ART General Before starting ART, each patient is evaluated to help maximize her chances for success and a healthy pregnancy. Chronic medical conditions such as diabetes, hypertension and asthma should be well controlled before attempting to conceive. Women planning an IVF cycle should optimize their weight. Obesity has been associated with infertility, a reduced chance of success with IVF, and an increase in the risk of miscarriage and preterm birth the American Society for Reproductive Medicine

Ovarian reserve test J Hum Reprod Sci Sep-Dec; 4(3): 108–113.

Evaluation before ART Uterus The uterus is usually evaluated prior to an IVF. Three methods can be used: HSG, SIS or hysteroscopy. Prior to IVF, a trial or “mock” transfer may be done. The purpose of this procedure is to determine the length and direction of the uterus. Semen A semen analysis should be reviewed. Changes in sperm quality may occur over time that could affect IVF success the American Society for Reproductive Medicine

Prerequisite test before ART Female HIV Hepatitis B antigen Hepatitis C antibody VDRL/RPR Pap smear Blood group, Rh, and antibody screen Male HIV Hepatitis B antigen Hepatitis C antibody VDRL/RPR Complex semen analysis, antisperm antibodies, and strict morphology 2011 the American Society for Reproductive Medicine

STRONGLY RECOMMENDED PRENATAL TESTS Female Rubella titer Varicella titer Hemoglobin electrophoresis Cervical swab for Gonorrhea and Chlamydia Male Hemoglobin electrophoresis 2011 the American Society for Reproductive Medicine

ART Cycle Pre-stimulation treatment Ovarian stimulation with gonadotropins Monitoring follicle development Final oocytes maturation Transvaginal oocyte retrieval Insemination Embryo transfer Progesterone supplementation Pregnancy test Early pregnancy follow-up 2011 the American Society for Reproductive Medicine

Ovarian stimulation with gonadotropins Santos M A et al. 2010;139:23-34 ©2009 by Society for Reproduction and Fertility

Ovulation induction VS. Controlled ovarian hyperstimulation Ovulation induction Use in anovulatory infertility. Restore physiologic of cyclic ovarian function. Aim : Ovulation of single follicle Controlled ovarian hyperstimulation Superovulation Stimulation of multiple follicular development Aim : multiple follicular development for ART 2011 the American Society for Reproductive Medicine

Controlled ovarian hyperstimulation Long agonistAntagonist Merck & Co., Inc

GnRH agonist / antagonist used to inhibit a premature LH surge

GnRH Agonists Gonadotropin releasing hormone (GnRH) is a hormone produced in the brain that indirectly stimulates ovarian function. Agonists of GnRH are synthetic forms of this hormone Mechanism Of Action Agonists of GnRH initially stimulate the pituitary gland to release all the stored gonadotropins (LH and FSH -the hormones that normally stimulate ovarian function). Over the course of a week to 10 days, GnRH analogs suppress the production of any new LH and FSH. This effect appears to prevent the ovaries from receiving mixed signals from the patient's own LH and FSH and from the medications that are administered to stimulate follicle development. The result for many patients is a more synchronized development of mature oocytes the American Society for Reproductive Medicine

GnRH agonist protocol Route of administration Days of cycle ( CD)Duration administration UltrashortNS / SC2,3 – 4,53 days ShortNS / SC2,3 until day of hCG8 -12 days Menstrual early cessationNS / SC21 until menses7 -12 days Follicular early cessationNS / SC21 until stimulate D6, days Long follicularNS / SC2 until day of hCG days Long follicular(depot)Depot2Once Long lutealNS / SC21 until day of hCG days Long luteal(depot)Depot21Once UltralongNS / SC / Depot2 or weeks, depot 2-3 times

GnRH agonist protocolAdvantasgeDisadvantage UltrashortPatient’s comfort, Poor respondersLow PR, Low oocyte quality No programming ShortPatient’s comfort, Poor respondersLow PR, Low oocyte quality No programming Menstrual early cessationInconclusiveLow E2 level, high cancel rate Follicular early cessationInconclusiveLow E2 level, high cancel rate Long follicularGood PR, High number oocytes, programmingLong duration Long follicular(depot)Patient’s comfortToo long duration of action Long lutealGood PR, programmingLong duration Long luteal(depot)Patient’s comfortToo long duration of action UltralongEndometriosis Sideeffects due to estrogen deficiency

GNRH Antagonists Antagonists of GnRH are directly and immediately inhibit FSH and LH production. Ultrasound measurements of follicular growth are used to determine when to start these medicines. Mechanism of Action GnRH antagonists bind to the receptor for gonoadotropin releasing hormone on the pituitary, preventing the natural luteinizing hormone surge and ovulation the American Society for Reproductive Medicine

GnRH antagonist protocols

Complex heterodimeric glycoproteins 2 non-covalent linked proteins: α - subunit: β - subunit: unique, specific hormonal function Gonadotropins ; use in ovarian stimulation

Pregnant mare serum Pig pituitary gland extracts Human menopausal gonadotropin (hMG) Recombinant human gonadotropins Exogenous gonadotropins

Corifollitropin alfa ;New long-acting gonadotropins

A heterodimeric glycoproteins Bind to receptor on the theca cells and granulosa cells (late follicular phase) Main role: Stimulate androgen production from the theca cells Triggering ovulation Supporting the corpus luteum Indication: Hypogonadotropic hypogonadism Profound pituitary & ovarian desensitization (GnRH agonist) Poor responder, age > 35 years Luteinzing hormone

Predict the ovarian response to gonadotropins. Monitor effect of pituitary down-regulation. Evaluate whether the dose of gonadotropin is adequate. Avoid OHSS Find the optimal time to give hCG COH monitoring : Why ? 2011 the American Society for Reproductive Medicine

Trigger ovulation; When? 3 follicles of 18 mm (mean of 2 diameters) on Day of stimulation and fewer than 15 follicles and Endometrial thickness : ≥ 7 mm. Drug used to trigger ovulation Urinary human chorionic gonadotrophin (uhCG) Recombinant hCG (rhCG) Recombinant LH (rLH) GnRH agonist Final oocytes maturation / trigger ovulation

Merck & Co., Inc

Success rate Success varies with many factors. Age of the woman is the most important factor Quality of embryos Number of embryos transferred J Hum Reprod Sci Sep-Dec; 4(3): 108–113.

Success rate Fresh Embryos From Non-Donor Oocytes 2014 SART